OTCMKTS:PKTX ProtoKinetix (PKTX) Stock Price, News & Analysis → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free PKTX Stock Alerts $0.01 0.00 (0.00%) (As of 04/17/2024 ET) Add Compare Share Share Today's Range$0.0142▼$0.016550-Day Range$0.01▼$0.0252-Week Range$0.01▼$0.03Volume173,334 shsAverage Volume148,176 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Get ProtoKinetix alerts: Email Address Ad Gold Safe ExchangeThe “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! About ProtoKinetix Stock (OTCMKTS:PKTX)ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions. It develops AAGP to treat dry-eye diseases. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Dalton, Ohio.Read More PKTX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PKTX Stock News HeadlinesApril 16, 2024 | markets.businessinsider.comNauticus Robotics And 2 Other Stocks Under $3 Insiders Are BuyingApril 9, 2024 | americanbankingnews.comProtoKinetix (OTCMKTS:PKTX) Shares Pass Below 50-Day Moving Average of $0.02April 18, 2024 | Gold Safe Exchange (Ad)The “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.November 18, 2023 | finance.yahoo.comProtoKinetix, Incorporated (PKTX)November 12, 2023 | morningstar.comProtoKinetix Inc PKTXOctober 30, 2023 | benzinga.comInsiders Buying ProtoKinetix And 2 Other Stocks Under $2June 6, 2023 | finance.yahoo.comResearch Paper Incorporating ProtoKinetix AAGP® Submitted to Scientific Journal for PublicationOctober 10, 2022 | reuters.comPKTX.PK - ProtoKinetix, Inc. | Stock Price & Latest News | ReutersApril 18, 2024 | Gold Safe Exchange (Ad)The “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.October 6, 2022 | benzinga.comProtoKinetix Stock (OTC:PKTX), DividendsJuly 20, 2022 | tmcnet.comProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell TransplantsJuly 17, 2022 | uk.investing.comAround $12 Million Bet On Sonim Technologies? 4 Penny Stocks Insiders Are BuyingJuly 15, 2022 | insidermonkey.comHedge Fund and Insider Trading News: Alan Howard, Cathie Wood, Elliott Management, Bridgewater Associates, Sonim Technologies Inc (SONM), ProtoKinetix, Incorporated (PKTX), and MoreJanuary 14, 2022 | finance.yahoo.comProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually OnlyNovember 23, 2021 | finance.yahoo.comProtoKinetix Announces Selection of AAGP® Candidate Formulations for Treatment of Dry Eye DiseaseAugust 9, 2021 | benzinga.com4 Penny Stocks Insiders Are BuyingSee More Headlines Receive PKTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ProtoKinetix and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/18/2024Next Earnings (Estimated)4/29/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:PKTX Previous SymbolNASDAQ:PKTX CUSIPN/A CIK1128189 Webwww.protokinetix.com Phone(330) 445-4971FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Clarence Edward Smith (Age 60)Chairman, President & CEO Mr. Michael Richard Guzzetta CPA (Age 66)Chief Financial Officer Comp: $60kKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors PKTX Stock Analysis - Frequently Asked Questions How have PKTX shares performed in 2024? ProtoKinetix's stock was trading at $0.0190 at the start of the year. Since then, PKTX shares have decreased by 25.3% and is now trading at $0.0142. View the best growth stocks for 2024 here. Are investors shorting ProtoKinetix? ProtoKinetix saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 3,500 shares, a drop of 31.4% from the March 15th total of 5,100 shares. Based on an average trading volume of 195,100 shares, the short-interest ratio is currently 0.0 days. View ProtoKinetix's Short Interest. When is ProtoKinetix's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, April 29th 2024. View our PKTX earnings forecast. What other stocks do shareholders of ProtoKinetix own? Based on aggregate information from My MarketBeat watchlists, some companies that other ProtoKinetix investors own include Fulcrum Therapeutics (FULC), Rockwell Medical (RMTI), Provention Bio (PRVB), VIVUS (VVUS), Actinium Pharmaceuticals (ATNM), Chimerix (CMRX), Rexahn Pharmaceuticals (REXN), SCYNEXIS (SCYX) and VBI Vaccines (VBIV). How do I buy shares of ProtoKinetix? Shares of PKTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PKTX) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeYour Money is Not SafeAmerican AlternativeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressOptions trading has suddenly become more reliable.Eagle Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProtoKinetix, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.